A study of the public‘s awareness of the causation of lung cancer

J. C. Murphy, G. Mates, B. Leahy, K. Proven (Manchester, United Kingdom)

Source: Annual Congress 2005 - Patient education, promotional research and best practice
Session: Patient education, promotional research and best practice
Session type: Thematic Poster Session
Number: 1187
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. C. Murphy, G. Mates, B. Leahy, K. Proven (Manchester, United Kingdom). A study of the public‘s awareness of the causation of lung cancer. Eur Respir J 2005; 26: Suppl. 49, 1187

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Evolution in the pathological study of lung cancer
Source: Virtual Congress 2020 – Management issues in thoracic oncology
Year: 2020


Prior lung disease and risk of lung cancer in women
Source: Eur Respir J 2005; 26: Suppl. 49, 598s
Year: 2005

Interstital lung disease rates and risk factors in a UK lung cancer screening trial
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018



A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Other cancers in lung cancer families are overwhelmingly smoking-related cancers
Source: ERJ Open Res, 3 (2) 00006-2017; 10.1183/23120541.00006-2017
Year: 2017



Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


A study of design an original questionnaire for evaluating risks of lung cancer
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011

A case-control study of environmental risk factors of lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 425s
Year: 2007

Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


The relationship of pain, uncertainty, and hope in Taiwanese lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 439s
Year: 2003

A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



The primary prevention of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009